Revitalist Initiates Collaborative Mental Health Campaign for Frontline Workers in the State of Maryland, USA

Share Post:

VANCOUVER, BC, January 13, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce a collaboration with Baltimore Ketamine Clinics and Lifestream Health Center with a goal to increase access to all frontline workers in the state of Maryland. 

The collaboration provides discounted services to frontline workers seeking treatments from any Maryland Revitalist, Baltimore Ketamine Clinic, or Lifestream Health Center facilities located in Bethesda, Sparks, Salisbury, or Bowie, Maryland. Ketamine infusions are offered at all locations, with vitamin infusion services offered at Bethesda, Sparks and Salisbury.

Recent reports indicate healthcare workers across the country have recognized increases in mental health concerns as staffing shortages continue across the country. The shortage has mandated the Centers for Disease and Control to update the guidelines for healthcare providers exposed to variants of COVID-19 decreasing their quarantine time up to 50% as compared to the general population1.

Revitalist CEO, Kathryn Walker states, “The president and founder of Baltimore Ketamine Clinics, Ivana Mitic, and Lifestream Health Center, CEO, Dr. Sarah Meritt share a common vision for synergistic alignment with Revitalist making this community partnership one of great value. The initiation of this campaign in the state of Maryland allows us to analyze the impact on the state as a whole with an expectation it will be positively duplicated to each of the 50 states”.

Revitalist will work with each clinic location to sponsor a national support group (“National Group”) through their telemedicine platforms allowing additional service offerings. The National Group will provide a sense of connectivity for frontline workers while the Omicron cases continue to grow. 



Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with seven clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For additional information and to be added to the Company’s mailing list, please click here.


Twitter:           @RevitalistCorp

Facebook:        @RevitalistLifestyleandWellnessLtd.

Instagram:       @RevitalistCorp

LinkedIn:          @RevitalistLifestyleAndWellnessLtd


On Behalf of the Board

Kathryn Walker

Chief Executive Officer


For further information please contact:

Revitalist Lifestyle and Wellness Ltd.

Email: [email protected]

Tel: (865) 585-8414

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.  

Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.


Stay Connected

More Press Releases

Psychedelic Community Reacts To FDA Committee’s Critique Of Lykos’ MDMA Studies Guest Column | June 14, 2024 As told to Abby Proch, executive editor of